V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006608 | 220021256 | 1.77 | 72.3 | Curative (C) | 2014-09-08 | 2014-09-08 | AML 19 TRIAL | N | N | 220030648 | AML19 TRIAL |
| 220006609 | 220002543 | 1.78 | 85 | Curative (C) | 2017-09-23 | 2017-09-28 | AML Relapsed FLA - Idarubicin | N | N | 220030651 | NOT MATCHED |
| 220006610 | 220002543 | 1.63 | 128.4 | Curative (C) | null | 2014-02-23 | AML 19 TRIAL | Y | N | 220030651 | AML19 TRIAL |
| 220006611 | 220002544 | 0.72 | 42 | Curative (C) | 2017-07-09 | 2017-10-13 | AML MyeChild 01 B Cytarabine/Daunoxome + GO | N | N | 220030653 | NOT MATCHED |
| 220006612 | 220002544 | 1.7 | 79.4 | Curative (C) | 2013-12-17 | 2013-12-25 | ALL Ph+ve Dasatinib Continuation | N | N | 220030653 | NOT MATCHED |
| 220006613 | 220002545 | 1.74 | 57 | Curative (C) | 2013-01-30 | 2013-01-30 | AML 19 TRIAL | Y | N | 220030661 | AML19 TRIAL |
| 220006614 | 220011467 | 1.65 | 105.5 | Curative (C) | 2016-07-15 | 2016-07-15 | AML 19 TRIAL | 01 | N | 220030664 | AML19 TRIAL |
| 220006615 | 220002546 | 1.68 | 17.4 | Palliative (P) | 2014-12-13 | 2014-12-13 | AML MyeChild 01 B Cytarabine/Daunoxome | 02 | N | 220030666 | NOT MATCHED |
| 220006616 | 220002546 | 1.73 | 71.2 | Curative (C) | 2016-11-01 | 2016-11-01 | FLAG + Idarubicin | 01 | N | 220030666 | FLAG + IDARUBICIN |
| 220006617 | 220002546 | 1.75 | 91 | Curative (C) | 2016-11-07 | 2016-11-08 | AML 19 TRIAL | Y | N | 220030666 | AML19 TRIAL |
| 220006618 | 220002546 | 1.59 | 101 | Curative (C) | 2014-07-01 | 2014-07-01 | AML 19 TRIAL | Y | null | 220030666 | AML19 TRIAL |
| 220006619 | 220002547 | null | 73.5 | Curative (C) | 2017-02-25 | 2017-02-28 | FLAG + Idarubicin | N | N | 220030679 | FLAG + IDARUBICIN |
| 220006620 | 220002547 | 1.63 | 94.3 | Curative (C) | 2016-05-12 | 2016-05-17 | FLAG + Idarubicin | N | N | 220030679 | FLAG + IDARUBICIN |
| 220006621 | 220002547 | 1.6 | 12.2 | Curative (C) | 2014-04-10 | 2014-04-11 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 220030679 | NOT MATCHED |
| 220006622 | 220002547 | 0 | 70.9 | null | 2013-02-06 | 2013-02-08 | Nilotinib | N | N | 220030679 | NILOTINIB |
| 220006623 | 220002547 | 1.57 | null | Curative (C) | 2013-04-08 | 2013-04-08 | null | N | N | 220030679 | NOT MATCHED |
| 220006624 | 220002547 | 1.61 | null | Disease modification (D) | 2013-02-04 | 2013-02-07 | Nilotinib | N | N | 220030679 | NILOTINIB |
| 220006625 | 220002548 | 0 | null | Curative (C) | 2013-05-24 | 2013-05-25 | Nilotinib | N | N | 220030693 | NILOTINIB |
| 220006626 | 220002548 | 0 | 101 | Disease modification (D) | 2017-03-13 | 2017-04-03 | Nilotinib | 99 | N | 220030693 | NILOTINIB |
| 220006627 | 220002549 | 1.87 | 68.4 | Curative (C) | 2014-09-13 | 2014-09-13 | AML 19 TRIAL | 01 | N | 220030695 | AML19 TRIAL |
| 220006628 | 220002549 | null | 52.1 | Curative (C) | 2016-02-06 | 2016-02-06 | AML MyeChild | N | N | 220030695 | NOT MATCHED |
| 220006629 | 220002549 | 0 | null | null | 2015-11-19 | 2016-10-27 | Nilotinib | 02 | null | 220030695 | NILOTINIB |
| 220006630 | 220002549 | 1.7 | 84 | Palliative (P) | 2016-06-19 | 2016-06-19 | FLAG + Idarubicin | 02 | N | 220030695 | FLAG + IDARUBICIN |
| 220006631 | 220002549 | 1.68 | 0 | Palliative (P) | 2015-05-22 | 2015-05-22 | Nilotinib | N | N | 220030695 | NILOTINIB |
| 220006632 | 220002549 | 1.54 | 64.6 | Curative (C) | 2015-08-21 | 2015-08-22 | FLAG + Idarubicin | N | N | 220030695 | FLAG + IDARUBICIN |
| 220006633 | 220021737 | null | null | Curative (C) | 2015-10-01 | 2015-10-01 | Nilotinib | N | N | 220030705 | NILOTINIB |
| 220006634 | 220021737 | 1.8 | 81 | Curative (C) | 2013-03-17 | 2013-03-23 | AML 19 TRIAL | Y | N | 220030705 | AML19 TRIAL |
| 220006635 | 220002550 | null | 52.4 | Curative (C) | 2017-04-09 | 2017-04-12 | AML 19 TRIAL | 01 | N | 220030710 | AML19 TRIAL |
| 220006636 | 220011472 | 1.78 | 66.2 | null | 2013-07-19 | 2013-07-19 | FLAG + Idarubicin | null | N | 220030712 | FLAG + IDARUBICIN |
| 220006637 | 220011472 | 1.73 | 79.2 | Curative (C) | 2017-08-06 | 2017-08-06 | AML 19 TRIAL | Y | N | 220030712 | AML19 TRIAL |
| 220006638 | 220002551 | 0.91 | 89.35 | Curative (C) | 2015-11-30 | 2015-11-30 | AML Interim Guidelines FLA -Ida | 2 | N | 220030714 | NOT MATCHED |
| 220006639 | 220002551 | 1.56 | 95.5 | Curative (C) | 2015-11-07 | 2015-11-07 | AML 19 TRIAL | 01 | N | 220030714 | AML19 TRIAL |
| 220006640 | 220002552 | 1.88 | 62.2 | Curative (C) | 2015-08-14 | 2015-08-14 | AML 19 TRIAL | Y | N | 220030719 | AML19 TRIAL |
| 220006641 | 220002553 | 0 | 108.7 | Adjuvant (A) | 2015-11-01 | 2015-11-05 | Nilotinib | N | N | 220030721 | NILOTINIB |
| 220006642 | 220002554 | 1.56 | null | Curative (C) | 2017-06-11 | 2017-06-14 | AML 19 TRIAL | 01 | null | 220030722 | AML19 TRIAL |
| 220006643 | 220002554 | null | 0 | Curative (C) | 2015-04-24 | 2015-04-29 | Nilotinib | N | N | 220030722 | NILOTINIB |
| 220006644 | 220002554 | 1.71 | 62.65 | Curative (C) | 2017-09-29 | 2017-10-02 | AML 19 TRIAL | 01 | N | 220030722 | AML19 TRIAL |
| 220006645 | 220002555 | 1.76 | 67.56 | Curative (C) | 2016-09-22 | 2016-09-23 | AML 19 TRIAL | 1 | N | 220030730 | AML19 TRIAL |
| 220006646 | 220002555 | 1.67 | 6 | Curative (C) | 2013-03-23 | 2013-03-26 | FLAG + Idarubicin | Y | null | 220030730 | FLAG + IDARUBICIN |
| 220006647 | 220002555 | 1.58 | 102 | Curative (C) | 2013-03-08 | 2013-03-08 | AML 19 TRIAL | Y | N | 220030730 | AML19 TRIAL |
| 220006648 | 220002556 | 0 | null | Curative (C) | null | 2013-04-30 | Nilotinib | N | N | 220030735 | NILOTINIB |
| 220006649 | 220002557 | 1.65 | null | Curative (C) | 2016-06-26 | 2016-07-03 | AML Interim Guidelines FLAG-Ida | N | null | 220030736 | FLAG + IDARUBICIN |
| 220006650 | 220002557 | null | 88.9 | null | 2014-06-05 | 2014-06-17 | Nilotinib | 02 | N | 220030736 | NILOTINIB |
| 220006651 | 220002558 | 0 | null | Disease modification (D) | 2016-01-19 | 2016-01-25 | Nilotinib | 2 | N | 220030738 | NILOTINIB |
| 220006652 | 220011477 | 1.78 | 82.8 | Curative (C) | 2016-11-24 | 2016-11-24 | AML 19 TRIAL | 1 | N | 220030739 | AML19 TRIAL |
| 220006653 | 220002559 | 1.73 | 48 | Curative (C) | 2014-05-21 | 2014-06-07 | APML HR Ind ATO + ATRA | N | N | 220030740 | NOT MATCHED |
| 220006654 | 220002559 | null | 63 | Curative (C) | 2014-06-10 | 2014-06-10 | Nilotinib | N | N | 220030740 | NILOTINIB |
| 220006655 | 220002560 | 1.74 | 74 | Curative (C) | 2013-08-03 | 2013-08-08 | AML 19 TRIAL | 1 | N | 220030748 | AML19 TRIAL |
| 220006656 | 220002560 | null | 98.2 | Curative (C) | 2017-10-16 | 2017-10-16 | FLAG + Idarubicin | 2 | N | 220030748 | FLAG + IDARUBICIN |
| 220006657 | 220002560 | 0 | 0 | Disease modification (D) | 2013-12-31 | 2014-01-02 | Nilotinib | N | N | 220030748 | NILOTINIB |